Quick Answer
MACROGENICS INC reported R&D Expense of $147.17 million for fiscal year 2025.
MACROGENICS INC R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $147.17M | -16.9% |
| 2024 | $177.19M | +6.4% |
| 2023 | $166.58M | -19.5% |
| 2022 | $207.03M | -3.5% |
| 2021 | $214.58M | +11.1% |
| 2020 | $193.20M | -1.1% |
| 2019 | $195.31M | +2.3% |
| 2018 | $190.83M | +29.6% |
| 2017 | $147.23M | +20.6% |
| 2016 | $122.09M | +24.2% |
| 2015 | $98.27M | +40.0% |
| 2014 | $70.19M | +50.7% |
| 2013 | $46.58M | +2.5% |
| 2012 | $45.43M | +10.6% |
| 2011 | $41.09M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $32.71M | -19.3% | -19.8% |
| June 30, 2025 | $40.79M | -21.1% | +2.8% |
| March 31, 2025 | $39.70M | -13.8% | -2.1% |
| September 30, 2024 | $40.54M | +34.6% | -21.6% |
| June 30, 2024 | $51.73M | +19.7% | +12.4% |
| March 31, 2024 | $46.03M | +0.3% | +52.8% |
| September 30, 2023 | $30.13M | -37.5% | -30.3% |
| June 30, 2023 | $43.23M | -16.5% | -5.8% |
- MACROGENICS INC showed a decrease of -16.9% in R&D Expense compared to the prior fiscal year.
- Over the 2011–2025 period, MACROGENICS INC’s r&d expense has grown by 258.2% (from $41.09 million to $147.17 million).
- The most recent figure is from MACROGENICS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 9, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: